What could be causing a female patient with a history of hyperparathyroidism, thrombocytosis, and elevated vitamin B12 levels, who discontinued progesterone and testosterone therapy, and is currently taking sermorelin (growth hormone-releasing hormone (GHRH) analogue) and tirzepatide (glucagon-like peptide-1 (GLP-1) receptor agonist), to experience delayed menstruation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Delayed Menstruation After Discontinuing Progesterone and Testosterone

The delayed menstruation is most likely caused by residual suppression of the hypothalamic-pituitary-ovarian axis from recent testosterone discontinuation, which disrupts normal ovarian function and endometrial development. 1

Primary Mechanism: Testosterone Withdrawal Effect

  • Exogenous testosterone disrupts normal ovarian function and endometrial development, causing menstrual delays even after discontinuation. 1 The suppressive effects on the HPO axis do not immediately resolve when testosterone is stopped, and it may take several weeks to months for normal cyclicity to resume.

  • The patient's history of hyperparathyroidism adds complexity, as both estradiol and progesterone can stimulate PTH secretion from abnormal parathyroid tissue. 2 However, this is unlikely to be the primary driver of menstrual delay.

  • Stress factors, including recent medication discontinuation, can further disrupt the hypothalamic-pituitary-ovarian axis and delay ovulation/menstruation. 1

Tirzepatide Considerations

  • Tirzepatide itself does not directly cause menstrual irregularities, but it has documented interactions with oral hormonal contraceptives due to delayed gastric emptying, particularly after the first dose. 3 However, this patient is not taking oral contraceptives.

  • In patients with hyperparathyroidism and chronic thiazide use, tirzepatide has been associated with severe hypercalcemia, 4 though this would not directly cause menstrual delay. Monitor calcium levels given the patient's hyperparathyroidism history.

  • Tirzepatide may indirectly affect ovarian function through interactions with IGF-1 and metabolic pathways, though this mechanism is not well-established. 1

Sermorelin (GHRH Analogue) Impact

  • Growth hormone secretion interacts with IGF-1 and metabolic function, which could indirectly affect ovarian function, 1 though this is not a primary mechanism for menstrual disruption.

  • No direct evidence links sermorelin to menstrual irregularities in the absence of other hormonal disruptions.

Diagnostic Algorithm

First, exclude pregnancy immediately using urine or serum β-hCG, as this is the most common cause of menstrual irregularity in reproductive-age women. 1

Second, obtain hormonal evaluation:

  • Measure LH, FSH, and estradiol levels to assess ovarian function recovery after testosterone discontinuation. 1
  • Calculate LH/FSH ratio (>2 suggests PCOS, though less likely with this clinical picture). 5
  • Check total testosterone to confirm clearance of exogenous testosterone. 5

Third, evaluate for complications:

  • Check serum calcium given hyperparathyroidism history and tirzepatide use. 4
  • Perform thyroid function tests (TSH, free T4), as thyroid dysfunction elevates SHBG and causes menstrual irregularities. 5
  • Consider pelvic ultrasound if hormonal tests suggest ovarian pathology. 5

Management Strategy

Discontinue or significantly reduce any remaining testosterone exposure to allow endogenous estrogen to rebuild the endometrium. 1 If testosterone was fully discontinued, allow 4-8 weeks for HPO axis recovery.

For symptomatic management of irregular bleeding if it occurs:

  • First-line: NSAIDs such as mefenamic acid 500 mg three times daily for 5 days OR celecoxib 200 mg daily for 5 days during bleeding episodes. 5, 6
  • Second-line: Low-dose combined oral contraceptives for 10-20 days if medically eligible and no contraindications (though avoid if bone health concerns exist). 5, 1

Consider progesterone withdrawal to induce menses once adequate endometrial development has occurred (typically 4-6 weeks after testosterone discontinuation). 1

Critical Pitfalls to Avoid

  • Do not assume a 10-day delayed period is "normal variation"—evaluate cycles >35 days apart as abnormal. 1

  • Do not continue testosterone at any dose without investigating its impact on menstrual function. 1

  • Do not overlook calcium monitoring in this patient with hyperparathyroidism taking tirzepatide, as severe hypercalcemia can occur, particularly with concurrent thiazide use. 4 Check baseline and follow-up serum calcium within 1-2 weeks.

  • Rule out pregnancy, thyroid dysfunction, and structural pathology before attributing menstrual delay solely to testosterone withdrawal. 5, 1

Referral Indications

Refer to endocrinology if:

  • Hormonal workup reveals complex endocrine abnormalities. 5
  • Calcium levels are elevated or PTH levels are abnormal. 4
  • Menstrual cycles do not resume within 3 months of testosterone discontinuation.

Refer to gynecology if:

  • Undiagnosed persistent or recurring abnormal vaginal bleeding occurs. 7
  • Pelvic ultrasound reveals structural abnormalities. 5

References

Guideline

Hormone Therapy and Menstrual Disruption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Elevated SHBG in Women with Irregular Periods

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Probiotics and Desogestrel Interaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the primary action of parathyroid hormone (PTH) in the body?
Is it safe to take Ajovy (fremanezumab) and tirzepatide at the same time?
What are the next steps for an elderly patient with elevated Parathyroid Hormone (PTH) levels?
Does taking Tirzepatide (a glucagon-like peptide-1 receptor agonist) affect the efficacy of hormonal birth control in a female patient with diabetes?
Does a 60-year-old African American male with diabetes, taking Mounjaro (tirzepatide), who presents to the emergency room (ER) with fatigue, lightheadedness, and nausea, and has a history of hypoglycemia, tachycardia, and metabolic acidosis with an elevated anion gap, require hospital admission for further evaluation and management?
What blood work is recommended for a female patient undergoing fertility testing?
What does an overnight dexamethasone (DST) suppression test with a cortisol level of 1.1 and a dexamethasone level of 426 indicate in a patient being evaluated for Cushing's syndrome?
What is the primary treatment goal and management plan for a patient with left ventricle diastolic function restrictive physiology, likely with underlying conditions such as hypertension, diabetes, or coronary artery disease?
What is the best treatment approach for a patient with postnasal drip, considering their medical history and potential allergies?
What is the best course of action for a 1-year-old child with a lingering cough for 5 weeks, despite recent treatment with cetirizine (hydroxyzine) for allergies, and a history of recent cold and pollen allergies?
What is the management approach for a 26-year-old female patient with regular menstrual periods, hyperprolactinemia (elevated prolactin levels) and unilateral nipple discharge?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.